Steris Corp (NASDAQ:STE) will unveil its latest earnings on Tuesday, August 2, 2011. STERIS Corporation is a provider of infection prevention and surgical products and services, focused mainly on the critical markets of healthcare, pharmaceutical and research.
Steris Corp Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for net income of 49 cents per share, a rise of 6.5% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 52 cents. Between one and three months ago, the average estimate moved down, but it has been unchanged at 49 cents during the last month. For the year, analysts are projecting profit of $2.35 per share, a rise of 7.3% from last year.
Past Earnings Performance: The company fell short of estimates last quarter after being in line with forecasts the quarter prior. In the fourth quarter of the last fiscal year, it reported net income of 61 cents per share versus a mean estimate of 63 cents. Two quarters ago, it reported profit of 57 cents per share.
Wall St. Revenue Expectations: On average, analysts predict $311.3 million in revenue this quarter, a rise of 6.9% from the year ago quarter. Analysts are forecasting total revenue of $1.42 billion for the year, a rise of 17.4% from last year’s revenue of $1.21 billion.
Analyst Ratings: Analysts are bullish on Steris as four analysts rate it as a buy, one rates it as a sell and three rate it as a hold.
The company’s revenue has now risen for two straight quarters. In fourth quarter of the last fiscal year, revenue increased 13.7% to $377.8 million from the year earlier quarter. In the third quarter of the last fiscal year, the figure rose 0.1%.
Competitors to Watch: Stryker Corporation (NYSE:SYK), Cantel Medical Corp. (NYSE:CMN), Medical Action Industries (NASDAQ:MDCI), Kinetic Concepts, Inc. (NYSE:KCI), Invacare Corporation (NYSE:IVC), Becton, Dickinson and Co. (NYSE:BDX), Hill-Rom Holdings, Inc. (NYSE:HRC), Thermo Fisher Scientific Inc. (NYSE:TMO), and Winner Medical Group, Inc (NASDAQ:WWIN).
Stock Price Performance: During July 21, 2011 to July 27, 2011, the stock price had dropped $1.58 (-4.3%) from $36.60 to $35.02. The stock price saw one of its best stretches over the last year between April 18, 2011 and April 29, 2011 when shares rose for nine-straight days, rising 7.1% (+$2.38) over that span. It saw one of its worst periods between May 31, 2011 and June 6, 2011 when shares fell for five-straight days, falling 5.1% (-$1.82) over that span. Shares are down $1.12 (-3.1%) year to date.
(Source: Xignite Financials)